How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

346 results for

Community Acquired Pneumonia Refractory to Standard Management

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Community Acquired Pneumonia Refractory to Standard Management

Community Acquired Pneumonia Refractory to Standard Management Community Acquired Pneumonia Refractory to Standard Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure (...) Miscellaneous Abuse Cancer Administration 4 Community Acquired Pneumonia Refractory to Standard Management Community Acquired Pneumonia Refractory to Standard Management Aka: Community Acquired Pneumonia Refractory to Standard Management From Related Chapters II. Indications No improvement after 72 hours of antibiotics for community acquired III. Causes resistant to current antibiotic spectrum See Empyema or Nosocomial superinfection Non-infectious cause of or other respiratory symptoms organizing Secondary

2018 FP Notebook

2. Community-Acquired Pneumonia (CAP) in Adults

. Whitney ; on behalf of the American Thoracic Society and Infectious Diseases Society of America Show All... PubMed: You may print one copy of this document at no charge. However, if you require more than one copy, you must place a reprint order. Domestic reprint orders: ; international reprint orders: . Abstract Section: Background: This document provides evidence-based clinical practice guidelines on the management of adult patients with community-acquired pneumonia. Methods: A multidisciplinary (...) , the availability of results from new therapeutic trials and epidemiological investigations led to revised recommendations for empiric treatment strategies and additional management decisions. Conclusions: The panel formulated and provided the rationale for recommendations on selected diagnostic and treatment strategies for adult patients with community-acquired pneumonia. Keywords : ; ... Show All Contents Section: Overview Introduction Methods Recommendations Question 1: In Adults with CAP, Should Gram Stain

2019 Infectious Diseases Society of America

3. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America

evidence-based clinical practice guidelines on the management of adult patients with community-acquired pneumonia. Methods: A multidisciplinary panel conducted pragmatic systematic reviews of the relevant research and applied Grading of Recommendations, Assessment, Development, and Evaluation methodology for clinical recommendations. Results: The panel addressed 16 specific areas for recommendations spanning questions of diagnostic testing, determination of site of care, selection of initial empiric (...) antibiotic therapy, and subsequent management decisions. Although some recommendations remain unchanged from the 2007 guideline, the availability of results from new therapeutic trials and epidemiological investigations led to revised recommendations for empiric treatment strategies and additional management decisions. Conclusions: The panel formulated and provided the rationale for recommendations on selected diagnostic and treatment strategies for adult patients with community-acquired pneumonia

2019 American Thoracic Society

4. The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age

The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America (...) | Clinical Infectious Diseases | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article navigation 1 October 2011 Article Contents Article Navigation The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America John S

Full Text available with Trip Pro

2011 Infectious Diseases Society of America

5. Community Acquired Pneumonia Refractory to Standard Management

Community Acquired Pneumonia Refractory to Standard Management Community Acquired Pneumonia Refractory to Standard Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure (...) Miscellaneous Abuse Cancer Administration 4 Community Acquired Pneumonia Refractory to Standard Management Community Acquired Pneumonia Refractory to Standard Management Aka: Community Acquired Pneumonia Refractory to Standard Management From Related Chapters II. Indications No improvement after 72 hours of antibiotics for community acquired III. Causes resistant to current antibiotic spectrum See Empyema or Nosocomial superinfection Non-infectious cause of or other respiratory symptoms organizing Secondary

2015 FP Notebook

6. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications

or refractory CDI, but non-CDI indica- tions are also considered. These guidelines only apply to adult patients (=18 years); the working party did not consider the role of FMT in the treatment of either CDI or non-CDI indications in children or young people. The guidelines were written with a focus on UK practice, but also with consideration of more global practice as it applied. The diagnosis and management of CDI in general are outside the remit of these guidelines. 4.3. Evidence appraisal Questions (...) of evidence: high; strength of recommendation: strong). 5.1.1.2. Refractory CDI Two randomised trials allowed the recruitment of patients with refractory CDI. The first defined this as at least 3 weeks of ongoing severe symptoms despite standard antimicrobial therapy for CDI. 17 The second required persistent or wors- ening diarrhoea and one of the following: ongoing abdom- inal pain, fever >38°C or white blood cell count >15×10 9 /l despite oral vancomycin at a dose of 500 mg four times daily

2018 British Society of Gastroenterology

7. Treatment Options for Relapsed or Refractory Multiple Myeloma

The newest agents have also become available in an era in which the costs of managing the condition and the financial burden borne by patients are substantial. The cost of a single course of drug therapy for MM in the United States has been estimated to range from $75,000 - $250,000 for patients with relapsed or refractory disease; these estimates are likely conservative, given the increasing use of triplet therapy and “treat to progression” labeling for the newest agents. 11 Out-of- pocket expenses (...) Treatment Options for Relapsed or Refractory Multiple Myeloma ©Institute for Clinical and Economic Review, 2016 Treatment Options for Relapsed or Refractory Multiple Myeloma: Effectiveness, Value, and Value-Based Price Benchmarks Final Evidence Report and Meeting Summary June 9, 2016 Institute for Clinical and Economic Review ©Institute for Clinical and Economic Review, 2016 Page ii Final Evidence Report – Multiple Myeloma Return to Table of Contents AUTHORS ICER Staff University of Washington

2017 California Technology Assessment Forum

8. Diagnosis and Management of Acute Pulmonary Embolism

Diagnosis and Management of Acute Pulmonary Embolism 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Search Account Menu Menu Navbar Search Filter Mobile Microsite (...) Search Term Close search filter search input Article Navigation Close mobile search navigation Article Navigation Article Contents Article Navigation 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) Stavros V Konstantinides Chairperson Germany/Greece Corresponding authors: Stavros

Full Text available with Trip Pro

2019 European Society of Cardiology

9. Management of Cardiovascular Diseases during Pregnancy

Management of Cardiovascular Diseases during Pregnancy We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy | European Heart Journal | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close (...) mobile search navigation Article navigation 07 September 2018 Article Contents Article Navigation 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy Vera Regitz-Zagrosek Chairperson Corresponding authors. Vera Regitz-Zagrosek, Charité Universitaetsmedizin Berlin, Institute for Gender in Medicine, CCR, DZHK, partner site Berlin, Hessische Str 3-4, 10115 Berlin, Germany, Tel: +49 30 450 525 288, Fax: +49 30 450 7 525 288, E-mail: . Search for other works by this author

Full Text available with Trip Pro

2018 European Society of Cardiology

10. 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza

%) and specificity (47%) among children aged <5 years [30]. In another prospective study among pediatric outpatients aged ≤13 years with respiratory infections, fever was the only reliable predictor of culture-confirmed influenza virus infection [40]. Influenza is an important cause of community-acquired pneumonia in adults [41]. Invasive bacterial coinfection may occur (with Staphylococcus aureus , Streptococcus pneumoniae , Streptococcus pyogenes [group A streptococci], and others) [42–45]. Secondary bacterial (...) . Recommendations (Abridged) Diagnosis I. Which patients should be tested for influenza? Outpatients (Including Emergency Department Patients) During influenza activity (defined as the circulation of seasonal influenza A and B viruses among persons in the local community) (see Figure 1): Clinicians should test for influenza in high-risk patients, including immunocompromised persons who present with influenza-like illness, pneumonia, or nonspecific respiratory illness (eg, cough without fever) if the testing

2019 Infectious Diseases Society of America

11. BSG consensus guidelines on the management of inflammatory bowel disease in adults

3.12.7 Sequential therapy (infliximab and ciclosporin) in refractory ASUC 52 3.12.8 Accelerated infliximab induction regimen in ASUC 52 3.12.9 Colectomy for ASUC 53 3.13 Surgical management in UC 54 3.13.1 Emergency colectomy for UC 54 3.13.2 Outcomes after colectomy for UC 55 3.13.3 Surgery in UC patients with primary sclerosing cholangitis 56 3.13.4 Fertility and delivery after restorative proctocolectomy 57 3.14 Pouches and pouchitis 57 3.14.1 Assessment of new symptoms after IPAA 57 3.14.2 (...) by Gut 10 th June 2019 1 Introduction In the past decade there have been major advances in investigations, pharmacological, non- pharmacological and surgical interventions for both ulcerative colitis (UC) and Crohn’s disease. In light of this, the British Society of Gastroenterology (BSG) Clinical Services and Standards Committee (CSSC) commissioned a new guideline for the management of inflammatory bowel disease (IBD) in adults. This was to replace the 2011 iteration of IBD guidelines from

2019 British Society of Gastroenterology

12. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy

or noncorticosteroid (eg, infliximab). May offer colonoscopy in cases where patients have been on immunosuppression and may be at risk for opportunistic infections as an independent cause for diarrhea (ie, CMV colitis) and for those who are anti-TNF or corticosteroid refractory. It is recommended that clinicians manage grade 4 toxicities as follows: Should permanently discontinue all ICPi treatment. Should admit patient when clinically indicated. Patients managed as outpatients should be very closely monitored (...) Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline | Journal of Clinical Oncology Search in: Menu Article Tools ASCO SPECIAL ARTICLE Article Tools OPTIONS & TOOLS COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2017.77.6385 Journal of Clinical

2018 American Society of Clinical Oncology Guidelines

13. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

Society of Endocrinology has initiated this guideline on the Management of Aggressive Pituitary DOI: Page(s): G1–G24 Volume/Issue: Article Type: Research Article Online Publication Date: Jan 2018 Copyright: © 2018 European Society of Endocrinology 2018 Free access Background Pituitary tumours are common and easily treated by surgery or medical treatment in most cases. However, a small subset of pituitary tumours does not respond to standard medical treatment and presents with multiple local (...) used as backbone for the guideline. Selected recommendation (i) Patients with aggressive pituitary tumours should be managed by a multidisciplinary expert team. (ii) Histopathological analyses including pituitary hormones and proliferative markers are needed for correct tumour classification. (iii) Temozolomide monotherapy is the first-line chemotherapy for aggressive pituitary tumours and pituitary carcinomas after failure of standard therapies; treatment evaluation after 3 cycles allows

Full Text available with Trip Pro

2018 European Society of Endocrinology

14. Guidelines on the management of acute respiratory distress syndrome

of Critical Care 2008;23:101-10. 125. Chan MC, Hsu JY, Liu HH, et al. Effects of prone position on inflammatory markers in patients with ARDS due to community-acquired pneumonia. Journal of the Formosan Medical Association 2007;106:708- 16. 126. Guerin C, Gaillard S, Lemasson S, et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: A randomized controlled trial. Journal of the American Medical Association 2004;292:2379-87. 54 127. Mancebo J, Fernandez R, Blanch L, et al (...) TECHNICAL SUMMARY The guidelines for the management of adult patients with ARDS were created by a multi-disciplinary writing group constituted by the Joint Standards Committee of the Faculty of Intensive Care Medicine (FICM) and the Intensive Care Society (ICS). All group members, including lay members, are co-authors of the guideline. The group first met in 2013 and completed the guidelines in 2018. The guidelines have undergone both independent external peer review and also input from stakeholder

2018 Intensive Care Society

15. BSR guideline Management of Adults with Primary Sjögren's Syndrome

Standards, Guideline and Audit Working Group, The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome, Rheumatology , Volume 56, Issue 10, October 2017, Pages e24–e48, Download citation file: © 2019 Oxford University Press Navbar Search Filter Mobile Microsite Search Term Close search filter search input , , , Background Primary Sjogren's Syndrome (pSS) is a classic, immune-mediated, condition of unknown aetiology characterized by focal lymphocytic (...) BSR guideline Management of Adults with Primary Sjögren's Syndrome We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome | Rheumatology | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input

Full Text available with Trip Pro

2017 British Society for Rheumatology

16. Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I)

glucocorticoid treatment in ARDS ( ). One of these trials was in patients with ARDS due to community-acquired pneumonia ( ) and another was a subgroup analysis of the initial corticosteroid trial in septic shock ( ). These trials consistently found that glucocorticoid treatment was associated with a significant reduction in markers of systemic inflammation (inflammatory cytokines and/or C-reactive protein levels), reduction in the duration of mechanical ventilation by approximately 7 days, and probable (...) trials; RR=0.93, 95% CI 0.80–1.08). Two trials examined the effects of hydrocortisone ( ) and hydrocortisone plus fludrocortisone ( ) specifically in trauma-associated CIRCI, as defined by a change in baseline cortisol at 60 min of < 9 μg/dL after cosyntropin (250 μg) administration. In the first trial ( n = 113 multiple trauma patients with CIRCI), hydrocortisone therapy prevented the development of hospital-acquired pneumonia by day 28 (hazard ratio [HR] 0.47, 95% CI 0.25–0.86) and increased by 6

2017 Society of Critical Care Medicine

17. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association

successfully implemented. , , , In Arizona, hospital bypass by emergency medical services to designated OHCA centers equipped to provide best-practice in-hospital care was associated with improved overall survival from 8.9% to 14.4%. The management of STEMI represents the paradigm for integrated systems of care with coordinated emergency medical services, community, and tertiary care centers, coupled with standardized hub-and-spoke transfer protocols, quality assurance, real-time feedback, and healthcare (...) . Regional protocols should standardize management practices, provide futility parameters, and determine the timing of transfer once the diagnosis of refractory CS is established. Figure 3. Proposed regional system of care for cardiogenic shock. ( A ) A patient with CS diagnosed in the field by EMS can be transported directly to the hub CS center, bypassing the nearest spoke facility. ( B ) CS pathogenesis, travel time, and spoke center capabilities should factor into the decision to bypass spoke

2017 American Heart Association

18. Gastro-oesophageal reflux disease in children and young people: diagnosis and management

in children and young people: diagnosis and management (NG1) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 16 of 36a single episode of pneumonia. 1.1.7 Consider referring infants and children with persistent back arching or features of Sandifer's syndrome (episodic torticollis with neck extension and rotation) for specialist assessment. 1.1.8 Recognise the following as possible complications of GOR in infants, children (...) if clinically indicated) no improvement in regurgitation after 1 year old persistent, faltering growth associated with overt regurgitation unexplained distress in children and young people with communication difficulties retrosternal, epigastric or upper abdominal pain that needs ongoing medical therapy or is refractory to medical therapy feeding aversion and a history of regurgitation unexplained iron-deficiency anaemia a suspected diagnosis of Sandifer's syndrome. 1.1.21 Consider performing an oesophageal

2015 National Institute for Health and Clinical Excellence - Clinical Guidelines

19. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline

on hospital-acquired infections or quality of life. The Task Force raised the possibility that a home-based management may have different effects among patients who are discharged from the emergency department compared to patients who are discharged following an initial hospitalisation. To address these concerns, a post hoc stratified analysis was performed (evidence profile 5); the results of these analyses did not provide convincing evidence to indicate differential effects among patients discharged (...) and patients in the trials were small, diminishing confidence in the estimated effects. There was no information reported for one outcome of interest to the Task Force, the rate of hospital-acquired infections. In addition, there was insufficient information to draw conclusions regarding another outcome of interest, quality of life ( i.e. among the three trials that reported quality of life, one did not provide standard deviations, another only provided St George's Respiratory Questionnaire scores

2017 European Respiratory Society

20. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

criteria Blood culture positive for IE Typical microorganisms consistent with IE from 2 separate blood cultures: Viridans streptococci, Streptococcus bovis , HACEK group, Staphylococcus aureus ; or community-acquired enterococci in the absence of a primary focus, or microorganisms consistent with IE from persistently positive blood cultures defined as follows: at least 2 positive cultures of blood samples drawn >12 h apart or all 3 or a majority of ≥4 separate cultures of blood (with first and last (...) of echocardiography in identifying clinically definite cases. Moreover, a retrospective study of 410 patients showed good agreement (72%–90%) between the Duke criteria and clinical assessment by infectious disease experts blinded to underlying IE risk factors. Several refinements have been made to both the major and minor Duke criteria. In the original Duke criteria, bacteremia resulting from S aureus or enterococci was considered to fulfill a major criterion only if it was community acquired because ample

Full Text available with Trip Pro

2016 Infectious Diseases Society of America

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>